In this study, we demonstrated that the plasma level of LRG1 was increased in adenomas (LGN) and CRCs, and the concentration of LRG1 was remarkably increased in human CRCs compared with adenomas and controls, which was consistent with data found in the literature[6, 25]. The gene discussed is LRG1; the disease is adenoma.